Clinical trial
Medtronic PERIcardial SurGical AOrtic Valve ReplacemeNt Pivotal Trial A Multi-center, Non-randomized Trial to Determine the Safety and Effectiveness of the Model 400 Aortic Valve Bioprosthesis in Patients With Aortic Valve Disease
NCT02088554 is registered in ClinicalTrials.gov with Medtronic Cardiac Surgery as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Medtronic PERIcardial SurGical AOrtic Valve ReplacemeNt Pivotal Trial A Multi-center, Non-randomized Trial to Determine the Safety and Effectiveness of the Model 400 Aortic Valve Bioprosthesis in Patients With Aortic Valve Disease
- Lead sponsor
- Medtronic Cardiac Surgery
- Phase
- Not applicable
- Overall status
- Active, not recruiting
- Start date
- May 12, 2014
- Completion date
- December 31, 2035
- Enrollment
- 1,312 (actual)
- Sites
- 38
Conditions
As the registry lists them; a condition with its own page is linked.
aortic stenosis